Be ready by anticipating and countering objections the employer might raise.

Under the terms of the deal with BBA, BBA acquired a capped 4.5% royalty on net sales of KSI-301 that will be paid upon marketing approval.

AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) and granted Priority Review for Imfinzi (durvalumab) for the treatment of patients with previously untreated extensive-stage small cell lung cancer (SCLC).

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

There are currently three antivirals approved by the U.S. Food and Drug Administration (FDA) for genital herpes. They are acyclovir (Sitavig and Zovirax), valacyclovir (Valtrex), and famciclovir (Famvir). There are no approved vaccines.

The gene sequencing industry has really taken off in the years since the Human Genome Project’s rough draft was announced in June 2000.

The final interview is probably the most intense and important interview you’ll go through, and here you want to show your in-depth knowledge of your industry, the role, and the organization, so your questions should reflect this high level of preparedness and research.

Bayer and Pharmaron have entered into a global collaboration agreement to develop new molecular entities for veterinary medicines. Under the collaboration, Bayer will fully leverage Pharmaron's Chemistry, Manufacturing and Controls (CMC) service platform.

With their expertise in the safe and effective use of medications, pharmacists can help in the management of chronic diseases. A review and analysis published in the British Journal of Clinical Pharmacology indicates that initiatives - such as patient education, medication review, and physical assessments - led by pharmacists can make important contributions to the prevention of cardiovascular disease.

Companies from across the globe provide updates on their businesses and pipelines.

In light of the Thanksgiving season, here are six things about biopharma that we are thankful for.

Many job seekers take it for granted that the holidays are not the best time to be on the job market, so they suspend their job hunt until after the new year. Others get distracted by all of the holiday hullabaloo and don’t put as much time and effort into their search as they need to.

Merck’s checkpoint inhibitor Keytruda (pembrolizumab) has been approved for 21 indications, but you’d better keep up, because it seems the drug is approved for some new indication or combination just about every week.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review for risdiplam, an investigational survival motor neuron-2 (SMN-2) splicing modifier for SMA. Risdiplam is designed to increase and sustain SMN protein levels both throughout the central nervous system and peripheral tissues of the body.

Researchers from VIB-UGent Center for Medical Biotechnology, University of Iowa (USA) and other collaborators, developed a novel approach to better understand a basic defense mechanism of our immune system. Central is ISG15, a small protein with a role in the immune system. With the newly developed method, scientists can now identify and study proteins tagged with ISG15, allowing them to

Previously, Toujeo was approved only for adults aged 18 years and older.

The companies are facing questions in a criminal probe regarding their marketing distribution practices related to the sale of opioids.

The government said Petit and former Chief Operating Officer William Taylor engaged in a scheme to “fraudulently inflate” the revenue of MiMedx.

While there is no cure for the disease, there are a number of drugs that have been approved to treat the illness. And with the growing number of cases, the drug market for COPD is expected to dramatically increase as well.

Regardless of your situation, the holidays are a busy time for just about anyone. But don’t forget about the people you’ve been sitting next to all day, every day for the better part of a year — your co-workers.